Despite the aforementioned limitations, this study represents the first to concurrently assess circulating levels of the hepatokine ApoJ and the myokine MSTN alongside muscle mass, muscle strength, and PP—the three core diagnostic domains of sarcopenia—to comprehensively examine their associations with sarcopenia in older adults. This evidence concerns the gene CLU and sarcopenia.